ChatBioGPT: Biomedical Conversational AI

• ChatBioGPT is a specialized conversational system for biology and medicine, capable of fluent technical and lay responses using transformer-based models.
• It integrates biomedical corpora and multimodal data for Q&A, literature summarization, and visual medical image analysis across diverse benchmarks.
• It is fine-tuned via pipelines like Alpaca and HealthCareMagic-100k, demonstrating promising performance in MDQA, bioinformatics coding, and privacy safeguards.

Searching arXiv for papers on ChatBioGPT and adjacent biomedical QA systems. ChatBioGPT denotes a class of conversational systems specialized for biology, biomedicine, and clinical medicine. In one formulation, it is “ChatGPT for biology and biomedicine”: a LLM specialized on biological and medical knowledge, capable of generating fluent answers to technical and lay questions alike; in a later implementation study, the same name is used for a medical chatbot finetuned from BioGPT on Alpaca and HealthCareMagic-100k (Apostolopoulos et al., 2023, Zhu et al., 25 Sep 2025). Across the literature, ChatBioGPT is situated within medical domain question answering (MDQA), multimodal biomedical analysis, and bioinformatics workflow assistance, but its outputs are repeatedly characterized as probabilistic continuations of biomedical language rather than mechanistic models of cells, organisms, or patients (Li et al., 2024).

1. Conceptual lineage and scope

ChatBioGPT inherits the operational logic of ChatGPT and related GPT systems. In the underlying account adopted for biology and medicine, a GPT is a Transformer sequence model trained on massive text corpora using unsupervised learning, estimating next-token distributions of the form $p(x_t \mid x_{<t})$ and minimizing a cross-entropy objective over large datasets (Apostolopoulos et al., 2023). A biomedical variant preserves the same attention layers, token embeddings, and autoregressive generation, but is trained or fine-tuned on biomedical corpora such as textbooks, peer-reviewed articles, clinical guidelines, drug labels, electronic health record text, genomic database annotations, and curated ontologies (Apostolopoulos et al., 2023).

Within the MDQA taxonomy, ChatBioGPT spans unimodal and multimodal systems. The text side includes encoder-only models such as BioBERT, PubMedBERT, BioLinkBERT, BioELECTRA, ClinicalBERT, BlueBERT, and SciBERT; decoder-only and generative systems such as BioGPT, BioGPT-Large, ClinicalGPT, ChiMed-GPT, GAL, BLOOM, MediTron, Med-PaLM 2, and PMC-LLaMA; and encoder–decoder families such as T5, Flan-T5, and CoT-T5. The multimodal side includes PubMedCLIP, BiomedCLIP, MedCLIP, MedFuseNet, M2I2, MedVInT, LLaVA-Med, Med-Flamingo, XrayGPT, CephGPT-4, Med-PaLM M, and MRGL (Li et al., 2024).

The term therefore covers more than one artifact. It names a domain-specialized conversational paradigm for biomedical question answering, literature use, image-grounded reasoning, and educational support, and it also names a specific small-language-model chatbot derived from BioGPT with 347M parameters (Zhu et al., 25 Sep 2025). This suggests that “ChatBioGPT” functions both as a generic architectural idea and as a concrete family of biomedical assistants.

2. Architectural patterns and system design

The core probabilistic objective in MDQA is framed as conditional answer generation, typically $$P(\text{answer} \mid \text{question}, \text{context})$$, and, in retrieval-augmented settings, $P(a \mid q, c; \theta)$ where $c$ is retrieved evidence (Li et al., 2024). For multimodal QA, the conditioning extends to images or other signals as $P(a \mid q, I; \theta)$, with vision encoders, fusion mechanisms, and medical-tuned LLMs supplying the joint representation (Li et al., 2024).

A concrete systems blueprint appears in Bio-Eng-LMM, a modular multimodal platform implemented in Python with Gradio, Flask, and Uvicorn. Its RAG stack uses preprocessed documents, real-time user-uploaded files, and web retrieval; embeddings are stored in Chroma; retrieved context is injected into prompts; and retrieval can use top-$k$ search and Maximum Marginal Relevance. The same platform integrates LLAVA for image understanding, Stable Diffusion XL for image generation, Whisper-base.en for speech recognition, session memory for conversational continuity, and DuckDuckGo-backed web search and summarization (Forootani et al., 2024). In an explicitly biomedical adaptation, such a design yields a system that can answer with local corpora, summarize papers and websites, reason over images, and preserve conversation state across research sessions.

The implementation called ChatBioGPT in the privacy literature follows a narrower but more concrete training pipeline. BioGPT is first finetuned on Alpaca to acquire instruction-following and conversational behavior, then finetuned on HealthCareMagic-100k to specialize it for medical question answering; reported hyperparameters include batch size 16, learning rate $2 \times 10^{-5}$, warmup ratio 0.03, cosine scheduling, AdamW, and 3 epochs (Zhu et al., 25 Sep 2025). No architectural modification beyond task adaptation is reported. The result is an SLM-based medical chatbot intended for symptom discussion, disease-oriented responses, and healthcare dialogue.

3. Biomedical question answering, multimodality, and visual analysis

The MDQA literature defines ChatBioGPT-like systems as assistants for reading comprehension, reasoning, diagnosis support, treatment recommendation, relation extraction, probability modeling, medical visual question answering, image captioning, report generation, cross-modal retrieval, and segmentation-supported explanation (Li et al., 2024). In the 2023 review of bioinformatics and biomedical informatics, these capabilities are illustrated by single-cell cell-type annotation from marker genes, open reading frame identification in viral sequences, biomedical QA, pathway and knowledge-graph reasoning, drug-discovery ideation, figure interpretation, and multimodal medical image understanding (Wang et al., 2024).

Multimodal work extends beyond classical medical imaging into specialized biometric and biological visual analysis. In zero-shot iris recognition, GPT-4 Turbo was used through multimodal image-plus-text prompting for verification, soft biometrics, presentation-attack detection, multi-image grouping, and limited cross-modality; across about 80 hard genuine and impostor pairs, it achieved roughly 70% accuracy, with strengths on some CASIA genuine cases and notable failures on ND-Iris-0405 and IIT-Delhi impostor or genuine pairs (Farmanifard et al., 2024). The same study reports that prompt phrasing matters: direct biometric prompts triggered refusals, whereas framing the task as a “puzzle,” “opinion,” or visual comparison, and using “eye” rather than “iris,” elicited more detailed analysis (Farmanifard et al., 2024).

A parallel face-biometrics assessment found that GPT-4, used through image input and prompt engineering that declared images to be AI-generated, reached 95.15% accuracy on LFW, 78.63% on AgeDB, and 88.69% on CFP-FP for face verification; on a 5,400-image real-face gender dataset it achieved 100% accuracy; and on 400 UTKFace images for age estimation it achieved 74.25% accuracy under an interval-containment criterion, with 100% on 100 synthetic faces under the same evaluation (Hassanpour et al., 2024). These results are not equivalent to a clinical imaging benchmark, but they show that ChatBioGPT-like multimodal systems can act as visual analysts in highly specialized domains when prompted appropriately.

The biomedical image literature adds a complementary point. GPT-4V is described as capable of medical VQA, biomedical image classification, and scientific figure interpretation, but OpenAI’s own limitations on closely spaced text, color perception, and spatial relationships remain relevant, and Wang et al. report “confirmation bias,” including cases where conclusions and rationales diverge (Wang et al., 2024). For a biomedical assistant, this makes explanation quality central but insufficient on its own.

4. Bioinformatics programming and research workflow support

ChatBioGPT is also defined by its role as a programming and workflow assistant. In computational biology, the documented use cases include code writing, reviewing, debugging, converting, refactoring, pipelining, data cleanup, visualization, scientific writing, and API integration (Rahman et al., 2023, Lubiana et al., 2023). The associated “prompt bioinformatics” model describes bioinformatics analysis as a workflow in which a researcher states data, goals, and constraints in natural language and receives code, explanations, or debugging guidance in return (Wang et al., 2024).

The most systematic classroom-scale test used 184 Python exercises from an introductory bioinformatics course. On its first attempt, ChatGPT solved 139 exercises, or 75.5%; within 7 or fewer attempts using natural-language feedback, it solved 179, or 97.3% (Piccolo et al., 2023). The solved tasks included sequence manipulation, file parsing, tabular data handling, regular expressions, and basic visualizations, while the unsolved tasks concentrated in multi-condition biological logic and edge-case handling such as in-frame codon detection and restriction-site logic (Piccolo et al., 2023).

Field reports in computational biology show the same pattern in less controlled settings. Rahman and Wong describe successful use of ChatGPT for BAM realignment workflows with BWA and SAMtools, FASTA counting with grep, Biopython-based BLAST scripting, edit-distance code, statistical plotting, Snakemake variant-calling pipelines, and command-line filtering with grep and awk; they also document hallucinated libraries, incorrect statistical choices such as multiple $t$-tests where ANOVA is more appropriate, and bioinformatics code that is syntactically correct but biologically naive (Rahman et al., 2023). The “Ten Quick Tips” paper places these practices in a broader workflow: improve documentation, write code efficiently, use chatbots for regex and label harmonization, refine data visualization, and generate methods text, but ensure that outputs are understood or testable and avoid dependence on the chatbot as the sole workflow engine (Lubiana et al., 2023).

Agentic frameworks extend this programming role. AutoBA designs analysis plans, generates code, manages package installation, executes code, and on 40 multi-omics scenarios reports 65% success for GPT-4 in end-to-end automation, improved further by feeding error messages back into the model. Mergen translates textual analysis descriptions into R code and refines them after execution errors, and BioMANIA builds chatbot interfaces over bioinformatics Python libraries by parsing source code and manuals, using a BERT-based recommender to select APIs and GPT-4 to predict parameters and execute calls (Wang et al., 2024). In this sense, ChatBioGPT is not just a QA engine but an orchestration layer over existing bioinformatics software.

5. Evaluation and empirical performance

The strongest general evaluation of zero-shot biomedical language capability compares ChatGPT with fine-tuned BioGPT and BioBART across relation extraction, document classification, question answering, and summarization. On BC5CDR, ChatGPT reached Precision 36.20, Recall 73.10, and F1 48.42, slightly above BioGPT’s F1 46.17; on KD-DTI it reached Precision 19.19, Recall 66.02, and F1 39.72; on HoC it reached F1 59.14 against BioGPT’s 85.12; and on PubMedQA it reached Accuracy 51.60 against BioGPT’s 78.20 (Jahan et al., 2023). In summarization, ChatGPT underperformed BioBART on large-training-set tasks such as iCliniq and HealthCareMagic, but on low-resource MEDIQA-ANS and MEDIQA-MAS it surpassed both BioBART-Base and BioBART-Large on ROUGE and BERTScore (Jahan et al., 2023). The authors’ conclusion is that zero-shot ChatGPT can outperform state-of-the-art fine-tuned generative biomedical transformers on some biomedical datasets with smaller training sets (Jahan et al., 2023).

The MDQA review situates these results in a larger model ecology. BioLinkBERT is reported at up to 94.8% on BioASQ and about 72.2 on PubMedQA; Med-PaLM 2 is reported at 86.5% on MedQA and 72.3% on MedMCQA; PMC-LLaMA-13B is described as outperforming ChatGPT on several benchmarks despite smaller size; MedFuseNet reaches about 63.6% on PathVQA; and MedVInT zero-shot reaches about 60.8% (Li et al., 2024). These figures place ChatBioGPT-like systems on a continuum from general-purpose LLM prompting to domain-pretrained and instruction-tuned biomedical models.

The specific SLM implementation named ChatBioGPT was evaluated on iCliniq with BERT-based BERTScore. Reported results were Precision $0.5565 \pm 0.0011$, Recall $0.5788 \pm 0.0009$, and F1 $$P(\text{answer} \mid \text{question}, \text{context})$$0, exceeding the corresponding BERT-based scores reported for ChatGPT and ChatDoctor in that study (Zhu et al., 25 Sep 2025). Using RoBERTa-based BERTScore, ChatDoctor scored slightly higher, but the authors argue that the BERT-based metric is more discriminating for medical precision (Zhu et al., 25 Sep 2025). This result is notable because the system uses a 347M-parameter BioGPT backbone and a comparatively lightweight finetuning pipeline.

The first-year review of 2023 synthesizes these empirical patterns into a broader judgment. ChatGPT-like models are already useful in omics, genetics, biomedical text mining, drug discovery, biomedical image understanding, programming, database query generation, and education, but their best performance often appears when they are connected to retrieval, curated tools, or structured benchmarks rather than asked to function as standalone biomedical oracles (Wang et al., 2024).

6. Reliability, governance, and privacy

The epistemic status of ChatBioGPT is repeatedly described as powerful but incomplete. Apostolopoulos et al. found that ChatGPT “appeared to be honest, self-knowledgeable, and careful with its answers,” yet also emphasized that it cannot independently evaluate source reliability, omits important concepts, may drift off-topic, inherits biases from training data, and remains a “black box” whose reasoning, memory use, and decision process are not directly inspectable (Apostolopoulos et al., 2023). In biomedicine, those limitations interact with patient safety, clinical responsibility, privacy, plagiarism, workforce change, and accountability.

Bias and misinformation concerns are amplified in healthcare because training data encode historical prejudice and because current systems “do not have a way to assess the correctness of” their own output (Apostolopoulos et al., 2023). The 2023 review therefore recommends human-in-the-loop workflows, retrieval grounding, prompt repositories, local deployment for sensitive data, and explicit governance over clinical or patient-facing use (Wang et al., 2024). Similar cautions appear in the computational-biology guidance: outputs should be treated as hypotheses, not ground truth; code should be unit-tested or run on toy data; and scientific statements should be checked against primary literature and package documentation (Lubiana et al., 2023).

Privacy has become a distinct research topic in the ChatBioGPT literature. In the 2025 study that finetunes ChatBioGPT from BioGPT, the authors inject synthetic name–disease pairs into HealthCareMagic entries and test whether the model memorizes and reveals them. Previous template-based attacks show extremely low attack success on the chatbot, but the proposed GEP method, based on greedy coordinate gradients, yields up to 60$$P(\text{answer} \mid \text{question}, \text{context})$$1 more leakage and reveals a PII leakage rate of up to 4.53% under free-style insertion (Zhu et al., 25 Sep 2025). The study shows that strong medical QA performance and low computational cost do not imply privacy safety, and it points toward de-identification, differential privacy, trigger detection, and leakage audits as necessary countermeasures (Zhu et al., 25 Sep 2025).

A further governance problem arises in biometric prompting. In face and iris studies, built-in safeguards were bypassed by prompt engineering that declared images to be AI-generated, reframed tasks as “puzzles” or visual comparisons, or replaced “biometric” language with less restricted wording (Hassanpour et al., 2024, Farmanifard et al., 2024). This suggests that multimodal biomedical assistants require safety mechanisms that are sensitive not only to text framing but also to the semantic content of images and to multi-step attack strategies.

ChatBioGPT thus occupies a double position in current research. It is an efficient and increasingly capable biomedical conversational architecture for QA, retrieval, summarization, coding assistance, and multimodal analysis; it is also a system whose outputs remain probabilistic, prompt-sensitive, bias-bearing, and, under adversarial conditions, capable of leaking memorized sensitive information (Li et al., 2024, Zhu et al., 25 Sep 2025). The literature consistently treats it as an assistive instrument embedded in expert oversight, evidence grounding, and formal governance rather than as an autonomous source of biological or clinical truth.